世界の神経障害疼痛治療市場2020-2024

◆英語タイトル:Global Neuropathy Pain Treatment Market 2020-2024
◆商品コード:IRTNTR43322
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月20日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは神経障害疼痛治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、適応別(糖尿病性神経障害、化学治療-神経因性疼痛含む、帯状疱疹後神経痛、その他)分析、薬物クラス別(カルシウムチャネルアルファ2デルタリガンド、SNRI、TCA、オピオイド鎮痛薬、その他)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・神経障害疼痛治療の世界市場:適応別(糖尿病性神経障害、化学治療-神経因性疼痛含む、帯状疱疹後神経痛、その他)
・神経障害疼痛治療の世界市場:薬物クラス別(カルシウムチャネルアルファ2デルタリガンド、SNRI、TCA、オピオイド鎮痛薬、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Neuropathy Pain Treatment Market 2020-2024

Technavio has been monitoring the neuropathy pain treatment market and it is poised to grow by $ 1702.89 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our reports on neuropathy pain treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the presence of large patient pool and focus toward the development of novel therapeutics for postherpetic neuralgia.

The neuropathy pain treatment market analysis includes type segment and geographic landscape.
Technavio’s neuropathy pain treatment market is segmented as below:
By Type
• Diabetic neuropathy
• Chemotherapy-induced neuropathy pain
• Postherpetic neuralgia
• Others

By Geographic Landscapes
• North America
• Europe
• APAC
• South America
• MEA

This study identifies the growing focus on the development of drugs for the treatment of diabetic neuropathy pain as one of the prime reasons driving the neuropathy pain treatment market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our neuropathy pain treatment market covers the following areas:
• Neuropathy pain treatment market sizing
• Neuropathy pain treatment market forecast
• Neuropathy pain treatment market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuropathy pain treatment market vendors that include Abbott Laboratories, Assertio Therapeutics Inc. , AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., and Sanofi. Also, the neuropathy pain treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-neuropathy-pain-treatment-market-2020-2024-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Indication
o Market segments
o Comparison by Indication
o Diabetic neuropathy – Market size and forecast 2019-2024
o Chemotherapy-induced neuropathy pain – Market size and forecast 2019-2024
o Postherpetic neuralgia – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by indication
• Market Segmentation by drug class
o Calcium channel alpha 2-delta ligands
o Serotonin-norepinephrine reuptake inhibitors (SNRIs)
o TCAs
o Opioid analgesics
o Others
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Assertio Therapeutics Inc.
o AstraZeneca Plc
o Baxter International Inc.
o Dr Reddy’s Laboratories
o Eli Lilly and Co.
o Endo International Plc
o Johnson & Johnson
o Pfizer Inc.
o Sanofi
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Other1 – Market share 2019-2024 (%)
• 22: Comparison by Other1
• 23: Diabetic neuropathy – Market size and forecast 2019-2024 ($ million)
• 24: Diabetic neuropathy – Year-over-year growth 2019-2024 (%)
• 25: Chemotherapy-induced neuropathy pain – Market size and forecast 2019-2024 ($ million)
• 26: Chemotherapy-induced neuropathy pain – Year-over-year growth 2019-2024 (%)
• 27: Postherpetic neuralgia – Market size and forecast 2019-2024 ($ million)
• 28: Postherpetic neuralgia – Year-over-year growth 2019-2024 (%)
• 29: Others – Market size and forecast 2019-2024 ($ million)
• 30: Others – Year-over-year growth 2019-2024 (%)
• 31: Market opportunity by Other1
• 32: Customer landscape
• 33: Market share by geography 2019-2024 (%)
• 34: Geographic comparison
• 35: North America – Market size and forecast 2019-2024 ($ million)
• 36: North America – Year-over-year growth 2019-2024 (%)
• 37: Europe – Market size and forecast 2019-2024 ($ million)
• 38: Europe – Year-over-year growth 2019-2024 (%)
• 39: APAC – Market size and forecast 2019-2024 ($ million)
• 40: APAC – Year-over-year growth 2019-2024 (%)
• 41: South America – Market size and forecast 2019-2024 ($ million)
• 42: South America – Year-over-year growth 2019-2024 (%)
• 43: MEA – Market size and forecast 2019-2024 ($ million)
• 44: MEA – Year-over-year growth 2019-2024 (%)
• 45: Key leading countries
• 46: Market opportunity by geography ($ million)
• 47: Impact of drivers and challenges
• 48: Vendor landscape
• 49: Landscape disruption
• 50: Industry risks
• 51: Vendors covered
• 52: Market positioning of vendors
• 53: Abbott Laboratories – Overview
• 54: Abbott Laboratories – Business segments
• 55: Abbott Laboratories – Key offerings
• 56: Abbott Laboratories – Key customers
• 57: Abbott Laboratories – Segment focus
• 58: Assertio Therapeutics Inc. – Overview
• 59: Assertio Therapeutics Inc. – Business segments
• 60: Assertio Therapeutics Inc. – Key offerings
• 61: Assertio Therapeutics Inc. – Key customers
• 62: Assertio Therapeutics Inc. – Segment focus
• 63: AstraZeneca Plc – Overview
• 64: AstraZeneca Plc – Business segments
• 65: AstraZeneca Plc – Key offerings
• 66: AstraZeneca Plc – Key customers
• 67: AstraZeneca Plc – Segment focus
• 68: Baxter International Inc. – Overview
• 69: Baxter International Inc. – Business segments
• 70: Baxter International Inc. – Key offerings
• 71: Baxter International Inc. – Key customers
• 72: Baxter International Inc. – Segment focus
• 73: Eli Lilly and Co. – Overview
• 74: Eli Lilly and Co. – Business segments
• 75: Eli Lilly and Co. – Key offerings
• 76: Eli Lilly and Co. – Key customers
• 77: Eli Lilly and Co. – Segment focus
• 78: Endo International Plc – Overview
• 79: Endo International Plc – Business segments
• 80: Endo International Plc – Key offerings
• 81: Endo International Plc – Key customers
• 82: Endo International Plc – Segment focus
• 83: Johnson & Johnson – Overview
• 84: Johnson & Johnson – Business segments
• 85: Johnson & Johnson – Key offerings
• 86: Johnson & Johnson – Key customers
• 87: Johnson & Johnson – Segment focus
• 88: Pfizer Inc. – Overview
• 89: Pfizer Inc. – Business segments
• 90: Pfizer Inc. – Key offerings
• 91: Pfizer Inc. – Key customers
• 92: Pfizer Inc. – Segment focus
• 93: Sanofi – Overview
• 94: Sanofi – Business segments
• 95: Sanofi – Key offerings
• 96: Sanofi – Key customers
• 97: Sanofi – Segment focus
• 98: Currency conversion rates for US$
• 99: Research Methodology
• 100: Validation techniques employed for market sizing
• 101: Information sources
• 102: List of abbreviations



【掲載企業】

Abbott Laboratories, Assertio Therapeutics Inc. , AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の神経障害疼痛治療市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆